In adults, do diabetes mellitus and systemic hypertension increase the risk of posterior subcapsular cataract, and what screening and management are recommended?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diabetes and Hypertension as Risk Factors for Posterior Subcapsular Cataract

Yes, both diabetes mellitus and systemic hypertension significantly increase the risk of posterior subcapsular (PSC) cataracts, with the combined presence of both conditions conferring an even greater risk than either condition alone.

Risk Magnitude

Diabetes mellitus increases PSC cataract risk with an odds ratio of 1.79, while hypertension increases risk with an odds ratio of 1.49, but when both conditions coexist, the combined risk escalates to an odds ratio of 2.66 1.

  • Hypertension is the most prominent single risk factor among cataract patients, present in 43.8% of patients with subcapsular cataracts specifically 2.
  • Diabetes mellitus shows a well-established association with PSC cataracts across multiple studies 3, 4, 1.
  • The combination of hypertension and diabetes creates a synergistic effect, more than doubling the baseline risk for cataract extraction 1.

Evidence Quality and Consistency

The evidence demonstrates remarkable consistency across multiple case-control studies:

  • A 1992 Veterans Administration study found that systemic hypertension significantly increased PSC cataract risk, with diabetes also showing strong association 3.
  • However, one 1989 Maryland-based case-control study (n=168 matched pairs) found that hypertension was NOT a risk factor for PSC cataracts, while diabetes was reconfirmed as a risk factor 4. This represents contradictory evidence on hypertension specifically.
  • The most comprehensive analysis from 1989 (n=161 cases, 196 controls) demonstrated clear dose-response relationships and combined effects 1.
  • The most recent 2019 study (n=812 patients) reinforces hypertension as the predominant risk factor in modern cataract populations 2.

Despite one contradictory study, the preponderance of evidence—including the largest and most recent investigation—supports both diabetes and hypertension as independent PSC cataract risk factors 3, 1, 2.

Clinical Implications

Screening Recommendations

  • Screen all diabetic and hypertensive patients for visual symptoms during routine medical visits 1, 2.
  • Patients with both conditions require heightened vigilance, as 98.4% of subcapsular cataract patients have at least one cardiovascular or metabolic risk factor 2.
  • Be aware that acute hyperglycemia in diabetics can cause transient PSC cataracts with feathery streak-like opacities that may resolve with glycemic control 5.

Management Considerations

  • Optimize blood pressure and glycemic control as primary prevention strategies, though direct evidence for cataract prevention through control is limited in these studies 1, 2.
  • Consider ophthalmology referral for patients with both diabetes and hypertension who report visual changes, given their 2.66-fold increased risk 1.
  • Note that furosemide use in hypertensive patients may further increase cataract risk (OR = 1.95), suggesting alternative antihypertensive agents may be preferable when clinically appropriate 1.

Important Caveats

  • Hypertension often progresses undetected for years, making early detection and treatment critical not only for cardiovascular protection but also for potential cataract risk reduction 2.
  • In young diabetic patients presenting with acute bilateral PSC cataracts, consider that these may be transient and related to acute hyperglycemia rather than permanent structural changes, warranting glycemic optimization before surgical intervention 5.
  • The protective effect of NSAIDs against cataracts appears significant only in hypertensive patients, though this finding requires confirmation 3.

References

Research

Systemic hypertension and senile cataracts: an epidemiologic study.

Optometry and vision science : official publication of the American Academy of Optometry, 1992

Research

Ultraviolet light exposure and risk of posterior subcapsular cataracts.

Archives of ophthalmology (Chicago, Ill. : 1960), 1989

Related Questions

What is the best approach for managing cataracts in an older patient with comorbidities such as diabetes (Diabetes Mellitus), hypertension (Hypertension), and a history of smoking?
How can I protect my eyes when my left eye has already developed a posterior subcapsular (PSC) cataract?
Does the development of a posterior subcapsular cataract (PSC) in my right eye indicate weaker left brain function or impaired function of the left side of my body?
What is the pathophysiology of posterior subcapsular cataract?
What are the preoperative clearance considerations for a 79-year-old patient undergoing cataract surgery with a history of hypertension, diabetes mellitus, and hyperlipidemia, currently on amlodipine, metoprolol, valsartan, and Paxil (paroxetine), and aspirin, following a recent carotid artery endarterectomy?
I am a healthy adult male with normal total testosterone, normal luteinizing hormone, normal follicle‑stimulating hormone, and normal sperm concentration; what are the likely causes and appropriate management for my low libido, erectile dysfunction, and perceived testicular shrinkage?
A 38-year-old woman with a new occipital headache that started two days ago at the onset of her menstrual period, who is normotensive and has no red‑flag symptoms, what is the most likely diagnosis and first‑line treatment?
Why does a 300 mg nightly dose of oral micronized progesterone cause somnolence?
In a patient with hyperkalemia and concurrent hypermagnesemia due to renal impairment, should sodium polystyrene sulfonate (Kalimate) be used as the primary treatment?
What are the recommended starting doses of metoprolol, spironolactone, lisinopril, and dapagliflozin in a patient with heart failure with reduced ejection fraction of 20–25%?
In a young adult with resistant hypertension despite two antihypertensive agents, which screening test is most appropriate?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.